Simon G - Search Results

1

Antiangiogenic agents in the management of non-small cell lung cancer: where do we stand now and where are we headed?

Aggarwal C, Somaiah N, Simon G. Aggarwal C, et al. Among authors: simon g. Cancer Biol Ther. 2012 Mar;13(5):247-63. doi: 10.4161/cbt.19594. Cancer Biol Ther. 2012. PMID: 22481432 Free PMC article. Review.

2

Small cell lung cancer.

Simon GR, Wagner H; American College of Chest Physicians. Simon GR, et al. Chest. 2003 Jan;123(1 Suppl):259S-271S. doi: 10.1378/chest.123.1_suppl.259s. Chest. 2003. PMID: 12527584 Review.

3

Taxanes in the treatment of advanced (stage III and IV) non-small cell lung cancer (NSCLC): recent developments.

Simon GR, Bunn PA Jr. Simon GR, et al. Cancer Invest. 2003;21(1):87-104. doi: 10.1081/cnv-120005919. Cancer Invest. 2003. PMID: 12643013 Review.

4

Gefitinib (ZD1839) in previously treated advanced non-small-cell lung cancer: experience from a single institution.

Simon GR, Ruckdeschel JC, Williams C, Cantor A, Chiappori A, Rocha Lima CM, Antonia S, Haura E, Wagner H, Robinson L, Sommers E, Alberts M, Bepler G. Simon GR, et al. Cancer Control. 2003 Sep-Oct;10(5):388-95. doi: 10.1177/107327480301000506. Cancer Control. 2003. PMID: 14581894 Free article. Clinical Trial.

5

RRM1 and PTEN as prognostic parameters for overall and disease-free survival in patients with non-small-cell lung cancer.

Bepler G, Sharma S, Cantor A, Gautam A, Haura E, Simon G, Sharma A, Sommers E, Robinson L. Bepler G, et al. Among authors: simon g. J Clin Oncol. 2004 May 15;22(10):1878-85. doi: 10.1200/JCO.2004.12.002. J Clin Oncol. 2004. PMID: 15143080

6

ERCC1 expression is a predictor of survival in resected patients with non-small cell lung cancer.

Simon GR, Sharma S, Cantor A, Smith P, Bepler G. Simon GR, et al. Chest. 2005 Mar;127(3):978-83. doi: 10.1378/chest.127.3.978. Chest. 2005. PMID: 15764785

7

Phase II study of first-line sequential chemotherapy with gemcitabine-carboplatin followed by docetaxel in patients with advanced non-small cell lung cancer.

Chiappori A, Simon G, Williams C, Haura E, Rocha-Lima C, Wagner H, Bepler G, Antonia S. Chiappori A, et al. Among authors: simon g. Oncology. 2005;68(4-6):382-90. doi: 10.1159/000086979. Epub 2005 Jul 12. Oncology. 2005. PMID: 16020967 Review.

8

Adjuvant chemotherapy for non-small cell lung cancer.

Crane EJ, Simon G. Crane EJ, et al. Among authors: simon g. Curr Treat Options Oncol. 2006 Jan;7(1):51-8. doi: 10.1007/s11864-006-0031-8. Curr Treat Options Oncol. 2006. PMID: 16343368 Review.

9

Phase I study of the taxane BMS-188797 in combination with carboplatin administered every 3 weeks in patients with solid malignancies.

Fishman MN, Garrett CR, Simon GR, Chiappori AA, Lush RM, Dinwoodie WR, Mahany JJ, Dellaportas AM, Cantor A, Gollerki A, Cohen MB, Sullivan DM. Fishman MN, et al. Clin Cancer Res. 2006 Jan 15;12(2):523-8. doi: 10.1158/1078-0432.CCR-05-0928. Clin Cancer Res. 2006. PMID: 16428495 Clinical Trial.

10

Combination of p53 cancer vaccine with chemotherapy in patients with extensive stage small cell lung cancer.

Antonia SJ, Mirza N, Fricke I, Chiappori A, Thompson P, Williams N, Bepler G, Simon G, Janssen W, Lee JH, Menander K, Chada S, Gabrilovich DI. Antonia SJ, et al. Among authors: simon g. Clin Cancer Res. 2006 Feb 1;12(3 Pt 1):878-87. doi: 10.1158/1078-0432.CCR-05-2013. Clin Cancer Res. 2006. PMID: 16467102 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results